BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cree BAC, Oksenberg JR, Hauser SL. Multiple sclerosis: two decades of progress. The Lancet Neurology 2022;21:211-4. [DOI: 10.1016/s1474-4422(22)00040-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Aloisi F, Giovannoni G, Salvetti M. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol 2023;22:338-49. [PMID: 36764322 DOI: 10.1016/S1474-4422(22)00471-9] [Reference Citation Analysis]
2 Barro C, Healy BC, Liu Y, Saxena S, Paul A, Polgar-turcsanyi M, Guttmann CR, Bakshi R, Kropshofer H, Weiner HL, Chitnis T. Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm 2023;10:e200052. [DOI: 10.1212/nxi.0000000000200052] [Reference Citation Analysis]
3 González-jiménez A, López-cotarelo P, Agudo-jiménez T, Martínez-ginés M, García-domínguez JM, Urcelay E, Espino-paisán L. Unraveling the Influence of HHEX Risk Polymorphism rs7923837 on Multiple Sclerosis Pathogenesis. IJMS 2022;23:7956. [DOI: 10.3390/ijms23147956] [Reference Citation Analysis]
4 Trobisch T, Zulji A, Stevens NA, Schwarz S, Wischnewski S, Öztürk M, Perales-Patón J, Haeussler M, Saez-Rodriguez J, Velmeshev D, Schirmer L. Cross-regional homeostatic and reactive glial signatures in multiple sclerosis. Acta Neuropathol 2022;144:987-1003. [PMID: 36112223 DOI: 10.1007/s00401-022-02497-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]